POSTPUBERTAL OUTCOME IN GIRLS DIAGNOSED OF PREMATURE PUBARCHE DURING CHILDHOOD - INCREASED FREQUENCY OF FUNCTIONAL OVARIAN HYPERANDROGENISM

被引:269
作者
IBANEZ, L
POTAU, N
VIRDIS, R
ZAMPOLLI, M
TERZI, C
GUSSINYE, M
CARRASCOSA, A
VICENSCALVET, E
机构
[1] UNIV PARMA, DEPT PEDIAT, I-43100 PARMA, ITALY
[2] UNIV PARMA, DEPT GYNECOL, I-43100 PARMA, ITALY
[3] AUTONOMOUS UNIV BARCELONA, HOSP MATERNO INFANTIL VALL HEBRON, HORMONAL LAB, BARCELONA, SPAIN
关键词
D O I
10.1210/jc.76.6.1599
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The postpubertal outcome of a group of girls diagnosed of premature pubarche during childhood was assessed 1) to determine the incidence of functional ovarian hyperandrogenism (FOH) through the ovarian-steroidogenic response to the GnRH agonist leuprolide acetate, 2) to validate leuprolide acetate stimulation in FOH diagnosis, and 3) to ascertain whether FOH-predictive biochemical markers exist at the diagnosis of premature pubarche. Of 35 patients (age, 15.4 +/- 1.5 yr), 16 showed hirsutism, oligomenorrhea, and elevated baseline testosterone and/or androstenedione (DELTA4-A) levels. Subcutaneous administration of leuprolide acetate (500 mug) produced similar increases in gonadotropin levels in oligomenorrheic patients, regularly menstruating patients (n = 19), and controls (n = 12; age, 15.3 +/- 1.3 yr) when tested at 6 h. Of all of the steroids measured, 17-hydroxyprogesterone (17-OHP) and DELTA4-A levels 24 h postleuprolide acetate stimulation were significantly higher in oligomenorrheic patients than in the other two groups (P < 0.0001). No overlapping in 17-OHP responses occurred between oligomenorrheic patients and the other groups. Baseline dehydroepiandrosterone sulfate and DELTA4-A levels at the diagnosis of premature pubarche correlated with 17-OHP values postleuprolide acetate challenge (r = 0.47; P < 0.005 and r = 0.67; P < 0.0001, respectively). These results show a distinct leuprolide acetate challenge response in 45% of the postpubertal premature pubarche girls studied, suggestive of an increased incidence of FOH, and support the need for continued routine postmenarcheal evaluation of this group of patients. Responses of 17-OHP to leuprolide acetate challenge facilitate the identification of FOH patients, establish this test as a reliable diagnostic tool in FOH diagnosis, and confirm the ovaries as the source of hyperandrogenemia in most patients with androgen excess. Although increased 17-OHP responses after leuprolide acetate stimulation seem to occur more frequently in girls with elevated dehydroepiandrosterone sulfate and/or DELTA4-A levels at the diagnosis of premature pubarche, specific biochemical markers predictive of FOH in this group of patients are still lacking.
引用
收藏
页码:1599 / 1603
页数:5
相关论文
共 26 条
[1]  
ABRAHAM GE, 1977, HDB RADIOIMMUNOASSAY, V5, P591
[2]  
ADAMS J, 1985, LANCET, V2, P1375
[3]   PREVALENCE OF POLYCYSTIC OVARIES IN WOMEN WITH ANOVULATION AND IDIOPATHIC HIRSUTISM [J].
ADAMS, J ;
POLSON, DW ;
FRANKS, S .
BRITISH MEDICAL JOURNAL, 1986, 293 (6543) :355-359
[4]  
ARDAENS Y, 1991, FERTIL STERIL, V55, P1062
[5]   THE POLYCYSTIC OVARY SYNDROME - PATHOGENESIS AND TREATMENT [J].
BARNES, R ;
ROSENFIELD, RL .
ANNALS OF INTERNAL MEDICINE, 1989, 110 (05) :386-399
[6]   PITUITARY OVARIAN RESPONSES TO NAFARELIN TESTING IN THE POLYCYSTIC OVARY SYNDROME [J].
BARNES, RB ;
ROSENFIELD, RL ;
BURSTEIN, S ;
EHRMANN, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (09) :559-565
[7]   DETECTION OF FUNCTIONAL OVARIAN HYPERANDROGENISM IN WOMEN WITH ANDROGEN EXCESS [J].
EHRMANN, DA ;
ROSENFIELD, RL ;
BARNES, RB ;
BRIGELL, DF ;
SHEIKH, Z .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (03) :157-162
[8]   CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN [J].
FERRIMAN, D ;
GALLWEY, JD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1961, 21 (11) :1440-+
[9]   NATURAL-HISTORY OF PREMATURE PUBARCHE - AN AUXOLOGICAL STUDY [J].
IBANEZ, L ;
VIRDIS, R ;
POTAU, N ;
ZAMPOLLI, M ;
GHIZZONI, L ;
ALBISU, MA ;
CARRASCOSA, A ;
BERNASCONI, S ;
VICENSCALVET, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (02) :254-257
[10]  
IBANEZ L, 1990, HORM RES S3, V33, P37